Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A real world retrospective chart review in patients with diabetic macular edema receiving ILUVIEN®

Trial Profile

A real world retrospective chart review in patients with diabetic macular edema receiving ILUVIEN®

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2018

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions
  • Acronyms USER
  • Most Recent Events

    • 13 Sep 2018 According to an Alimera Sciences media release, data from this study will be presented at the 2018 Annual Meeting of the Retina Society (Sep 2018).
    • 08 Nov 2017 According to an Alimera Sciences media release, updated data from this trial will be presented at 2017 Annual Meeting of the American Academy of Ophthalmology (AAO).
    • 07 Nov 2017 According to an Alimera Sciences media release, data from this trial will be presented at the Ophthalmology Innovation Summit (OIS) 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top